ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets, for oral use.

ODEFSEY is a prescription medicine. ODEFSEY is used for HIV infection Treatment.
INDICATIONS AND USAGE
ODEFSEY is a three-drug combination of emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV nucleoside analog reversetranscriptase inhibitors (NRTIs), and rilpivirine (RPV), a non-nucleoside reverse transcriptase inhibitor (NNRTI), and is indicated as a complete regimen for the treatment of HIV-1 infection in patients 12 years of age and older as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies per mL; or to replace a stable antiretroviral regimen in those who are virologicallysuppressed (HIV-1 RNA less than 50 copies per mL) for at least six months with no history of treatment failure and no known substitutions associated with resistance to the individual components of ODEFSEY
DOSAGE FORMS & STRENGTHS
Tablets: 200 mg of FTC, 25 mg of RPV and 25 mg of TAF
Manufactured By: Gilead Sciences, Inc
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “ODEFSEY® (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.